Global Image-guided Biopsy Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10241280

Publication Date:

October 22, 2024

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Image-guided Biopsy market size was valued at US$ 915.6 million in 2023. With growing demand in downstream market, the Image-guided Biopsy is forecast to a readjusted size of US$ 1654.3 million by 2030 with a CAGR of 8.8% during review period.
The research report highlights the growth potential of the global Image-guided Biopsy market. Image-guided Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Image-guided Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Image-guided Biopsy market.
Image-guided biopsy makes the use of imaging technologies in order to analyze the inside of the body. They utilized MIR, CT, ultrasound and x-ray for this procedure. The biopsy assists the medical professional to get the sample of the suspicious cell easily through the insertion of the needle into the best position. It is considered one of the best ways to collect samples as it causes no unnecessary injuries.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Image-guided Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Image-guided Biopsy market. It may include historical data, market segmentation by Type (e.g., X- Ray, Ultrasound), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Image-guided Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Image-guided Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Image-guided Biopsy industry. This include advancements in Image-guided Biopsy technology, Image-guided Biopsy new entrants, Image-guided Biopsy new investment, and other innovations that are shaping the future of Image-guided Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Image-guided Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Image-guided Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Image-guided Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Image-guided Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Image-guided Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Image-guided Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Image-guided Biopsy market.
Market Segmentation:
Image-guided Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
X- Ray
Ultrasound
Mammograpy
CT
MRI
Others
Segmentation by application
Hospitals
Ambulatory Surgery Centers
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Koninklijke Philips
Siemens Healthcare
Analogic Corporation
General Electric
Varian Medical Systems
Brainlab
Medtronic
Olympus Corporation
KARL STORZ Endoscopy India
Stryker

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Image-guided Biopsy Market Size 2019-2030
2.1.2 Image-guided Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Image-guided Biopsy Segment by Type
2.2.1 X- Ray
2.2.2 Ultrasound
2.2.3 Mammograpy
2.2.4 CT
2.2.5 MRI
2.2.6 Others
2.3 Image-guided Biopsy Market Size by Type
2.3.1 Image-guided Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Image-guided Biopsy Market Size Market Share by Type (2019-2024)
2.4 Image-guided Biopsy Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgery Centers
2.4.3 Clinics
2.4.4 Others
2.5 Image-guided Biopsy Market Size by Application
2.5.1 Image-guided Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Image-guided Biopsy Market Size Market Share by Application (2019-2024)
3 Image-guided Biopsy Market Size by Player
3.1 Image-guided Biopsy Market Size Market Share by Players
3.1.1 Global Image-guided Biopsy Revenue by Players (2019-2024)
3.1.2 Global Image-guided Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Image-guided Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Image-guided Biopsy by Regions
4.1 Image-guided Biopsy Market Size by Regions (2019-2024)
4.2 Americas Image-guided Biopsy Market Size Growth (2019-2024)
4.3 APAC Image-guided Biopsy Market Size Growth (2019-2024)
4.4 Europe Image-guided Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Image-guided Biopsy Market Size Growth (2019-2024)
5 Americas
5.1 Americas Image-guided Biopsy Market Size by Country (2019-2024)
5.2 Americas Image-guided Biopsy Market Size by Type (2019-2024)
5.3 Americas Image-guided Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Image-guided Biopsy Market Size by Region (2019-2024)
6.2 APAC Image-guided Biopsy Market Size by Type (2019-2024)
6.3 APAC Image-guided Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Image-guided Biopsy by Country (2019-2024)
7.2 Europe Image-guided Biopsy Market Size by Type (2019-2024)
7.3 Europe Image-guided Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Image-guided Biopsy by Region (2019-2024)
8.2 Middle East & Africa Image-guided Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Image-guided Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Image-guided Biopsy Market Forecast
10.1 Global Image-guided Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Image-guided Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Image-guided Biopsy Forecast
10.1.3 APAC Image-guided Biopsy Forecast
10.1.4 Europe Image-guided Biopsy Forecast
10.1.5 Middle East & Africa Image-guided Biopsy Forecast
10.2 Americas Image-guided Biopsy Forecast by Country (2025-2030)
10.2.1 United States Image-guided Biopsy Market Forecast
10.2.2 Canada Image-guided Biopsy Market Forecast
10.2.3 Mexico Image-guided Biopsy Market Forecast
10.2.4 Brazil Image-guided Biopsy Market Forecast
10.3 APAC Image-guided Biopsy Forecast by Region (2025-2030)
10.3.1 China Image-guided Biopsy Market Forecast
10.3.2 Japan Image-guided Biopsy Market Forecast
10.3.3 Korea Image-guided Biopsy Market Forecast
10.3.4 Southeast Asia Image-guided Biopsy Market Forecast
10.3.5 India Image-guided Biopsy Market Forecast
10.3.6 Australia Image-guided Biopsy Market Forecast
10.4 Europe Image-guided Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Image-guided Biopsy Market Forecast
10.4.2 France Image-guided Biopsy Market Forecast
10.4.3 UK Image-guided Biopsy Market Forecast
10.4.4 Italy Image-guided Biopsy Market Forecast
10.4.5 Russia Image-guided Biopsy Market Forecast
10.5 Middle East & Africa Image-guided Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Image-guided Biopsy Market Forecast
10.5.2 South Africa Image-guided Biopsy Market Forecast
10.5.3 Israel Image-guided Biopsy Market Forecast
10.5.4 Turkey Image-guided Biopsy Market Forecast
10.5.5 GCC Countries Image-guided Biopsy Market Forecast
10.6 Global Image-guided Biopsy Forecast by Type (2025-2030)
10.7 Global Image-guided Biopsy Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Koninklijke Philips
11.1.1 Koninklijke Philips Company Information
11.1.2 Koninklijke Philips Image-guided Biopsy Product Offered
11.1.3 Koninklijke Philips Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Koninklijke Philips Main Business Overview
11.1.5 Koninklijke Philips Latest Developments
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Information
11.2.2 Siemens Healthcare Image-guided Biopsy Product Offered
11.2.3 Siemens Healthcare Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Siemens Healthcare Main Business Overview
11.2.5 Siemens Healthcare Latest Developments
11.3 Analogic Corporation
11.3.1 Analogic Corporation Company Information
11.3.2 Analogic Corporation Image-guided Biopsy Product Offered
11.3.3 Analogic Corporation Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Analogic Corporation Main Business Overview
11.3.5 Analogic Corporation Latest Developments
11.4 General Electric
11.4.1 General Electric Company Information
11.4.2 General Electric Image-guided Biopsy Product Offered
11.4.3 General Electric Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 General Electric Main Business Overview
11.4.5 General Electric Latest Developments
11.5 Varian Medical Systems
11.5.1 Varian Medical Systems Company Information
11.5.2 Varian Medical Systems Image-guided Biopsy Product Offered
11.5.3 Varian Medical Systems Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Varian Medical Systems Main Business Overview
11.5.5 Varian Medical Systems Latest Developments
11.6 Brainlab
11.6.1 Brainlab Company Information
11.6.2 Brainlab Image-guided Biopsy Product Offered
11.6.3 Brainlab Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Brainlab Main Business Overview
11.6.5 Brainlab Latest Developments
11.7 Medtronic
11.7.1 Medtronic Company Information
11.7.2 Medtronic Image-guided Biopsy Product Offered
11.7.3 Medtronic Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Medtronic Main Business Overview
11.7.5 Medtronic Latest Developments
11.8 Olympus Corporation
11.8.1 Olympus Corporation Company Information
11.8.2 Olympus Corporation Image-guided Biopsy Product Offered
11.8.3 Olympus Corporation Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Olympus Corporation Main Business Overview
11.8.5 Olympus Corporation Latest Developments
11.9 KARL STORZ Endoscopy India
11.9.1 KARL STORZ Endoscopy India Company Information
11.9.2 KARL STORZ Endoscopy India Image-guided Biopsy Product Offered
11.9.3 KARL STORZ Endoscopy India Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 KARL STORZ Endoscopy India Main Business Overview
11.9.5 KARL STORZ Endoscopy India Latest Developments
11.10 Stryker
11.10.1 Stryker Company Information
11.10.2 Stryker Image-guided Biopsy Product Offered
11.10.3 Stryker Image-guided Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Stryker Main Business Overview
11.10.5 Stryker Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂